Compare PSQH & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSQH | ECOR |
|---|---|---|
| Founded | 2021 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.7M | 52.4M |
| IPO Year | N/A | 2018 |
| Metric | PSQH | ECOR |
|---|---|---|
| Price | $0.77 | $5.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $4.00 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 3.4M | 72.4K |
| Earning Date | 03-12-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $27,534,522.00 | ★ $29,835,000.00 |
| Revenue This Year | N/A | $28.92 |
| Revenue Next Year | $45.49 | $32.50 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 196.08 | 27.90 |
| 52 Week Low | $0.62 | $4.16 |
| 52 Week High | $3.97 | $19.49 |
| Indicator | PSQH | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 33.29 | 45.62 |
| Support Level | $0.70 | $5.15 |
| Resistance Level | $0.80 | $5.73 |
| Average True Range (ATR) | 0.07 | 0.55 |
| MACD | 0.00 | -0.18 |
| Stochastic Oscillator | 30.04 | 17.49 |
PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.